📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis. (2016)

First Author: Lynch BM

Attributed to: MICA: Evaluation of the selective endothelin A-receptor antagonist zibotentan as a treatment for renal disease in systemic sclerosis (scleroderma) funded by MRC

Abstract

No abstract provided

Bibliographic Information

PubMed Identifier: 27749244

Publication URI: http://europepmc.org/abstract/MED/27749244

Type: Journal Article/Review

Volume: 34 Suppl 100

Parent Publication: Clinical and experimental rheumatology

Issue: 5

ISSN: 0392-856X